
World wide shipping
online service for 24 x 7
Updated Product Catalog

CAS No. : [145739-56-6]
MDL No. : MFCD00936868
Synonyms : OPC6535
IUPAC Name : 6-(2-(3,4-Diethoxyphenyl)thiazol-4-yl)picolinic acid
| Price And Availability | ||||
|---|---|---|---|---|
| Pack Size | Price in USD | Add To Shopping Cart | Availability | Shipping Status |
| 5MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 10MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 25MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 50MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 100MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 250MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 500MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 1G | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
![]() | ||||
| Note: Tetomilastis not in stock but can be available through custom synthesis. The estimated lead-time is 4-6 weeks. The product will be characterized by NMR and Mass analysis. Purity (HPLC) is usually >98%. COA, QC data and SDS will be provided along with the product. For information on pricing and availability please contact us at sales@syninnova.com or Request A Quote. We respond promptly. Thank You! | ||||
| Chemical Properites | |
|---|---|
Mol. Formula : C19H18N2O4S | Mol. Weight : 370.42 |
Appearance : Solid | Melting Point : Not available |
| For Laboratory research use only, not for drug, household or other uses. | |
Applications : Tetomilast is a novel thiazole phosphodiesterase-4 (PDE-4) inhibitor, which may prove useful in both the treatment of inflammatory bowel disease (IBD) and chronic obstructive pulmonary disease (COPD). The pharmacological profile of Tetomilast revealed an IC50 value of 380 nM, which is weaker than those of Roflumilast and Cilomilast. Moreover, it has a long half-life (approximately 24h) and high bioavailability (nearly 100%), which are better than those of Roflumilast and Cilomilast. These data support Tetomilast as a suitable once-daily orally administered candidate.
References : Mulhall A. M. et al.: Expert Opin. Invest. Drugs 24, 1597-1611, 2015; Ti H. et al.: J. Med. Chem., 62(13), 5944-5978, 2019.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.
Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!
Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!
Recently Viewed Products |
|---|
Related Products |
|---|